Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Olodaterol

Olodaterol synthesis

2synthesis methods
Olodaterol, also known as BI 1744, is a long acting beta-adrenoceptor agonist used as an inhalation for treating patients with chronic obstructive pulmonary disease (COPD), manufactured by Boehringer-Ingelheim. Olodaterol was approved by FDA in 2014 for the treatment of chronic obstructive pulmonary disease.
Synthetic Routes
  • ROUTE 1
  • 202112070173898364.jpg

    Bouyssou, Thierry; Hoenke, Christoph; Rudolf, Klaus; Lustenberger, Philipp; Pestel, Sabine; Sieger, Peter; Lotz, Ralf; Heine, Claudia; Buettner, Frank H.; Schnapp, Andreas; Konetzki, Ingo. Discovery of olodaterol, a novel inhaled β2-​adrenoceptor agonist with a 24h bronchodilatory efficacy. Bioorganic & Medicinal Chemistry Letters. Volume 20. Issue 4. Pages 1410-1414. Journal. (2010).

  • ROUTE 2
  • 202112070687762503.jpg

    Tian, Miao; Xie, Xue-xing; Ma, Lu; Shen, Xue-yan; Chen, Chang-qing. A new generation of inhaled long-​acting β2-​adrenoceptor agonist olodaterol. Xiandai Yaowu Yu Linchuang. Volume 28. Issue 2. Pages 227-231. Journal; General Review. (2013).

  • ROUTE 3
  • 202112078345264838.jpg

    Yu, Xiong; Zhang, Yuanwei; Yuan, Xilun. Crystal form C of Olodaterol hydrochloride and its preparation method. Assignee Shanghai Front Health Pharmaceutical Technology Co., Ltd., Peop. Rep. China; Joincare Pharmaceutical Industry Group Co., Ltd. CN 108822054. (2018).

202112070173898364.jpg

Bouyssou, Thierry; Hoenke, Christoph; Rudolf, Klaus; Lustenberger, Philipp; Pestel, Sabine; Sieger, Peter; Lotz, Ralf; Heine, Claudia; Buettner, Frank H.; Schnapp, Andreas; Konetzki, Ingo. Discovery of olodaterol, a novel inhaled β2-​adrenoceptor agonist with a 24h bronchodilatory efficacy. Bioorganic & Medicinal Chemistry Letters. Volume 20. Issue 4. Pages 1410-1414. Journal. (2010).

869478-13-7 Synthesis
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one

869478-13-7
44 suppliers
inquiry

-

Yield:868049-49-4 99.27%

Reaction Conditions:

with palladium 10% on activated carbon;hydrogen in methanol at 50; under 2250.23 Torr;

Steps:

1.3 3) Preparation of crude odastatol hydrochloride
60 g (0.117 mol) prepared in the step 2) 6-Benzyloxy-8-{(R)-1-hydroxy-2-[2-(4-methoxy-phenyl)- 1,1-Dimethyl-ethylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one, 600 ml of methanol and 8 g of 10% palladium on carbon were added to the reaction flask and heated to 50 ° C. , hydrogenation under 3 bar of hydrogen pressure. Then, the catalyst was removed by suction filtration, and the solvent was evaporated to dryness to dryness to give 49.1 g of white foamy solid, yield: 99.27%. Purity: 95.3%.

References:

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd.;Yu Xiong;Zhang Yuanwei;Yuan Xilun CN109096218, 2018, A Location in patent:Paragraph 0074; 0079-0080

FullText

Olodaterol Related Search: